Trials Starting With "O"

OASIS-5: Organization for the Assessment of Strategies for Ischemic Syndromes

      -Preliminary Results

      -Women's Substudy by Dr. Eva Swahn

OASIS-6: Organization for the Assessment of Strategies for Ischemic Syndromes

      -Efficacy and Safety of Fondaparinux in Elderly Patients With ST-Segment Elevation Myocardial Infarction: Data From the OASIS 6 Trial by Dr. Ron J.G. Peters

      -Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) Trial by Dr. Salim Yusuf (ACC 2006)

      -Late-Breaking Trial Presentation by Dr. Mehta and Dr. Yusuf

OAT: Occluded Artery Trial

      -Trial Overview by Dr. Judith S. Hochman (AHA 2006)

      -Trial Overview by Dr. Judith S. Hochman (AHA 2006) Portuguese

      -Lots of Bucks, Not much Bang by Dr. Daniel B. Mark (AHA 2007)

OCCULT-MI: Optimal Cardiovascular Diagnostic Evaluation Enabling Faster Treatment of Myocardial Infarction

      -The 80 Lead ECG Body Surface Map: Can We Detect More STEMI Than with a 12 Lead ECG? by Dr. James Hoekstra (Lumen 2009)

OCTAMI: A Prospective, Randomized, Controlled Study Performed with Optical Coherence Tomography

      -Six-Month Strut Coverage and Vessel Wall Response of the Zotarolimus Eluting Stent Compared to Driver Bare Metal Stent Implanted in AMI by Dr. Giulio Guagliumi, et al. (TCT 2009)

Optical Coherence Tomography Study

      -Evaluation by Optical Coherence Tomography (OCT) of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After Implantation by Dr. Masamichi Takano

ONTARGET: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial

      -Trial Overview (2008)

ON-TIME-2: Ongoing-Tirofiban In Myocardial Infarction Evaluation

      -Trial Overview by Dr. Christian W. Hamm (ACC 2008)

      -One Year Follow-Up by Dr. Christian W. Hamm

OP Rx of PE with Dalteparin: Ongoing-Tirofiban In Myocardial Infarction Evaluation

      -Outpatient Treatment of Acute Pulmonary Embolism: Review of Published Studies by Dr. Amjad AlMahameed

OPTIC: Optimal Pharmacological therapy in Implantable Cardioverter Defibrillator Patients

      -Trial Overview by Dr. Stuart J. Connolly (ACC 2005)

OPTIMUS: Optimizing Antiplatelet Therapy in Diabetes Mellitus

      -Trial Overview by Dr. Dominick J. Angiolillo (2007)

OPTIMUS-2: Optimizing Antiplatelet Therapy in Diabetes Mellitus

      -Results of the OPTIMUS-2 Study by Dr. Dominick J. Angiolillo (CRT 2008)

 

OSCAR: The Comparison of High-Dose Angiotensin II Receptor Blocker (ARB) Monotherapy versus Combination Therapy of ARB with Calcium Channel Blocker on Cardiovascular Events in Japanese Elderly High-Risk Hypertensive Patients

      -Trial Overview by Dr. Hisao Ogawa (ACC 2011)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster